Warfarin Management for Diagnostic Cardiac Catheterization
Stop warfarin 5 days before a diagnostic cardiac catheterization and ensure the INR is <1.5 before proceeding with the procedure. 1, 2, 3, 1, 4
Pre-Procedure Management
Timing of Warfarin Interruption
- Discontinue warfarin exactly 5 days before the procedure 1, 2, 3, 1
- This 5-day interruption allows sufficient time for the INR to normalize, as warfarin's anticoagulant effect persists for 2-5 days after discontinuation 5
- The half-life of Factor II (prothrombin) is approximately 60 hours, requiring this extended washout period 5
Pre-Procedure INR Requirements
Check the INR immediately before the cardiac catheterization to confirm it is <1.5 1, 2, 3
Cardiac catheterization carries intermediate-to-high bleeding risk, particularly with potential for vascular access complications. The Canadian Cardiovascular Society guidelines specifically state that procedures with intermediate or high bleeding risk should proceed only when INR is <1.2, though the more widely adopted threshold across multiple international guidelines is <1.5 1, 2, 3.
Bridging Considerations
Bridging anticoagulation is NOT routinely recommended for most patients 6, 2, 4
However, bridging with LMWH should be considered ONLY for patients at high thromboembolic risk 1:
- CHADS₂ score ≥3
- Mechanical heart valve (especially mitral position)
- Stroke or TIA within the past 3 months
- Rheumatic heart disease
- Recent VTE (<3 months)
If bridging is used:
- Start LMWH 2 days after stopping warfarin (when INR drops below 2.0) 1
- Give the last dose of LMWH at least 24 hours before the procedure 1
- Still verify INR <1.5 before proceeding 2
Post-Procedure Management
Resume warfarin on the evening of the procedure (within 12-24 hours) at the usual maintenance dose once adequate hemostasis is achieved 1, 2, 3, 4
- Cardiac catheterization is considered a procedure with low-to-intermediate post-procedural bleeding risk
- Hemostasis is typically achieved within 18-25 minutes with modern closure devices 7
- Warfarin can safely be restarted the same evening as the procedure 2, 3
- Check INR one week later to ensure therapeutic anticoagulation has been re-established 2, 3
If bridging therapy was used:
- Restart therapeutic-dose LMWH 24-48 hours after the procedure 1
- Continue LMWH until INR returns to therapeutic range 2
Important Clinical Considerations
Patient-Specific Factors Requiring Longer Interruption
Consider extending the warfarin interruption period beyond 5 days for 4:
- Elderly patients with comorbidities
- Patients requiring very low warfarin doses
- Patients with higher target INR ranges (e.g., INR 3.0-3.5)
- Patients with declining renal function
Alternative Approach: Uninterrupted Anticoagulation
Recent evidence suggests that diagnostic cardiac catheterization can be performed safely without interrupting warfarin when using radial access and vascular closure devices 8, 9, 7. This approach showed no increase in bleeding complications in multiple studies, with INR values up to 3.5 9. However, this remains a specialized approach and is not yet standard practice in most guidelines.
Common Pitfalls to Avoid
- Do NOT double the warfarin dose to "catch up" if doses are missed 5
- Do NOT assume all patients need bridging—this significantly increases bleeding risk without clear benefit in most cases 6, 4
- Do NOT proceed with the catheterization if INR remains >1.5, as this substantially increases bleeding risk 1, 2
- Do NOT delay warfarin resumption beyond 24 hours unless there is active bleeding, as this increases thromboembolic risk 4
The evidence consistently supports the 5-day interruption protocol across multiple high-quality international guidelines from cardiology, gastroenterology, and hematology societies, making this the standard of care for elective cardiac catheterization 1, 2, 3, 1, 4.